Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes (Q30239737)

29 September 2017

1 reference

title

Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes (English)

1 reference

29 September 2017

0 references

1 reference

3

Amir Zarrinpar

0 references

William Jeffery Sandborn

5

object named as

William J Sandborn

1 reference

29 September 2017

Siddharth Singh

1

1 reference

29 September 2017

Parambir S Dulai

2

1 reference

29 September 2017

Amir Zarrinpar

3

1 reference

29 September 2017

Sonia Ramamoorthy

4

1 reference

29 September 2017

language of work or name

English

0 references

publication date

30 November 2016

1 reference

Nature Reviews Gastroenterology & Hepatology

29 September 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 September 2017

14

1 reference

29 September 2017

110-121

1 reference

29 September 2017

2

1 reference

25-year weight gain in a racially balanced sample of U.S. adults: The CARDIA study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Inflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Comparative Effectiveness and Safety of Anti-Tumor Necrosis Factor Agents in Biologic-Naive Patients With Crohn's Disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The Intestinal Immune System in Obesity and Insulin Resistance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Morbid Obesity is Associated with Increased Mortality, Surgical Complications, and Incremental Health Care Utilization in the Peri-Operative Period of Colorectal Cancer Surgery

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Dysbiosis: A Review Highlighting Obesity and Inflammatory Bowel Disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Outcomes of Bariatric Surgery in Patients with Inflammatory Bowel Disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Association between high visceral fat area and postoperative complications in patients with Crohn's disease following primary surgery.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The global burden of IBD: from 2015 to 2025.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The association between quitting smoking and weight gain: a systemic review and meta-analysis of prospective cohort studies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Assessment of mucosal healing in inflammatory bowel disease: review.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Population pharmacokinetics-pharmacodynamics of vedolizumab in patients with ulcerative colitis and Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Effect of lifestyle weight loss intervention on disease severity in patients with psoriasis: a systematic review and meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Impact of metabolic syndrome on the hospitalization rate of Crohn's disease patients seen at a tertiary care center: a retrospective cohort study.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Diet in the pathogenesis and treatment of inflammatory bowel diseases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Measures of obesity and risk of Crohn's disease and ulcerative colitis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Bariatric surgery in patients with inflammatory bowel disease: an accessible path? Report of a case series and review of the literature.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Comparative efficacy of biologic therapy in biologic-naïve patients with Crohn disease: a systematic review and network meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Role of fat and adipokines in intestinal inflammation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Obesity in autoimmune diseases: not a passive bystander

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The role of physical exercise in inflammatory bowel disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

A systematic review of the effect of oral glucocorticoids on energy intake, appetite, and body weight in humans.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Enteroendocrine cells in gastrointestinal pathophysiology

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Differences in visceral fat and fat bacterial colonization between ulcerative colitis and Crohn's disease. An in vivo and in vitro study

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Association between plasma concentrations of certolizumab pegol and endoscopic outcomes of patients with Crohn's disease.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Obesity increases risk for pouch-related complications following restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Gut microbiota, enteroendocrine functions and metabolism

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

High fat diet accelerates pathogenesis of murine Crohn's disease-like ileitis independently of obesity

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The increasing weight of Crohn's disease subjects in clinical trials: a hypothesis-generatings time-trend analysis.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Teduglutide in Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Comparative effectiveness of infliximab and adalimumab for Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Does morbid obesity change outcomes after laparoscopic surgery for inflammatory bowel disease? Review of 626 consecutive cases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study).

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Stoma issues in the obese patient

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Inflammatory bowel disease in the obese patient

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Impact of obesity on drug metabolism and elimination in adults and children

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The impact of obesity on perioperative outcomes after laparoscopic colorectal resection

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The impact of obesity on outcomes following major surgery for Crohn's disease: an American College of Surgeons National Surgical Quality Improvement Program assessment

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Adipokines in inflammation and metabolic disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The role of adipose tissue and adipokines in obesity-related inflammatory diseases

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Macrophages, inflammation, and insulin resistance

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Leptin: a critical regulator of CD4+ T-cell polarization in vitro and in vivo

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Adipokine signaling in inflammatory bowel disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Nucleotide oligomerization domains 1 and 2: regulation of expression and function in preadipocytes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Body mass index in children with newly diagnosed inflammatory bowel disease: observations from two multicenter North American inception cohorts.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Profiling adipocytokine secretion from creeping fat in Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Adipokines: inflammation and the pleiotropic role of white adipose tissue

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

The weight of leptin in immunity

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Preadipocyte conversion to macrophage. Evidence of plasticity.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Leptin: a pivotal mediator of intestinal inflammation in mice

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Annual medical spending attributable to obesity: payer-and service-specific estimates

3 June 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

High prevalence of overweight and obesity in adults with Crohn's disease: associations with disease and lifestyle factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

The effect of body weight on the severity and clinical course of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Visceral adipocytes: old actors in obesity and new protagonists in Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Effect of adiponectin on murine colitis induced by dextran sulfate sodium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Adiponectin deficiency protects mice from chemically induced colonic inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Adiponectin stimulates proliferation and cytokine secretion in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

The role of adiponectin in inflammatory gastrointestinal diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Crohn's disease affecting the small bowel is associated with reduced appetite and elevated levels of circulating gut peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Complications and functional results after ileoanal pouch formation in obese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Imaging obese patients: problems and solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Crohn’s disease remission on bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Risk of asthma and autoimmune diseases and related conditions in patients hospitalized for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Population pharmacokinetics of golimumab in patients with ankylosing spondylitis: impact of body weight and immunogenicity.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Stoma complications: a multivariate analysis

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5550405

Is obesity a risk factor for Crohn's disease?

26 November 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Crohn's disease clinical course and severity in obese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Inflammatory alterations in mesenteric adipose tissue in Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Resistin, an adipokine with potent proinflammatory properties

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Resistin is an inflammatory marker of inflammatory bowel disease in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

The impact of increased body mass index on the clinical course of Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Co-morbid diabetes in patients with Crohn's disease predicts a greater need for surgical intervention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: results from a randomized, multicenter, phase-3 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Body mass index and clinical response to infliximab in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Reply to Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

Norepinephrine suppresses IFN-γ and TNF-α production by murine intestinal intraepithelial lymphocytes via the β₁ adrenoceptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2016.181

10.1038/NRGASTRO.2016.181

31 March 2020

Identifiers

DOI

1 reference

release_xbsezgmnzrcwzgoztbcqwf2wme

29 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xbsezgmnzrcwzgoztbcqwf2wme

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

29 September 2017

1 reference